Key Takeaways
- Execution dip, margin gain: Revenue declined YoY as bioenergy project execution slowed, but gross margin improved to 47% on softer raw material prices and a favorable sales mix.
- The order book is 100% starchy: Sugary feedstock contracts vanished from the market this quarter; every new bioenergy order is now grain-based, with maize emerging as the feedstock of choice.
- GenX facility is capitalized but empty: The Mangalore plant is carrying depreciation without meaningful revenue; four global EPC approvals are in hand, but order conversion is slow and revenue is expected only from Q4 onwards.
- Services is the quiet outperformer: H1 services revenue already 40% higher than the full previous year, driven by performance enhancers and O&M, with CBG and pressmud products still to join the basket.
- What to watch next quarter: Whether the promised H2 order inflow recovery in engineering and exports actually materializes, the pace of GenX revenue ramp-up, and any policy-driven movement in sugary feedstock ordering.
Bioenergy: The Feedstock Shift Is Complete
- Sugary feedstock orders vanished: No sugary feedstock contracts were finalized in the quarter, not just for Praj but across the entire market. The order book mix is now effectively 100% starchy feedstock, with sugary described as a "miniscule number."
- Maize is the new center of gravity: Every new bioenergy order is on starchy feedstock, and maize has become the focus for the entire value chain. Grain-based ethanol viability, however, faces a headwind from high indicative FCI grain prices.
- The ban's hangover lingers: YoY execution declined because the government's ban on rice and sugary feedstock was notified "a bit too late in the year." Projects that would have executed in H1 did not go through, and even if construction starts now, the 4-6 month timeline means missing the current season.
- Starchy projects face funding friction: Plants based on starchy feedstock are moving "fairly okay," but some are encountering bank funding issues that are slowing progress.
- Policy signal, no market movement yet: The government lifted restrictions on cane juice, cane syrup and B-heavy molasses for ethanol production, but this has not yet translated into any significant market activity. Sugar plants are waiting for long-term policy visibility before committing to further investment.
Joshipura: "However, the indicative grain price is very high, posing a big challenge on project viability."
Praj GenX & Engineering: Capitalized, Approved, Waiting
- The facility is ready, revenue is not: The Mangalore GenX facility was capitalized after starting operations in Feb-Mar last year, so depreciation is hitting H1 numbers without corresponding revenue. The last six months were spent securing customer approvals, not executing orders.
- Four approvals, one order: Approvals have been received from four leading global EPC companies, but only one order is currently under execution, from a customer who approved the facility in Sep-Oct last year. The approval-to-order conversion cycle is long.
- Revenue inflection promised from Q4: Management expects revenue from the GenX facility to "start kicking in meaningfully maybe from Q4, and definitely from next year."
- Engineering order inflow has been rangebound: For the past 3-4 quarters, engineering order inflow has averaged ₹200-250 crores. With the new facility and approvals now in place, order booking is expected to build up meaningfully from H2 onwards.
- Export weakness is a timing issue, not a demand problem: Large engineering and bioenergy contracts could not close during the quarter, but the pipeline and dialogues are described as very strong. Management expects export orders to be back to normal by the end of nine months.
Services: The Silent Growth Engine
- H1 revenue already exceeds full-year FY24: Services revenue in H1 FY25 is 40% higher than the entire previous year, driven by performance enhancers (both domestic and international) and O&M contracts.
- New contributors are queuing up: CBG plants reaching operational maturity and pressmud-based performance enhancers are expected to start contributing to the services revenue stream, adding to the existing momentum.
- Biogenic CO2 capture is emerging as a distinct product line: Already with a few installations, this is seeing concentrated movement globally and is finding higher interest alongside fermentation process management services.[9-10]
- Management declines to disclose absolute services revenue: When asked for the H1 absolute number, the company stated it does not provide segmental figures, so the growth rate is the only disclosed metric.
New Molecules & New Markets
- Biopolymer demo facility is live: A multipurpose facility, described as India's first for biopolymers, has been commissioned. The first molecule demonstrated is lactic acid, followed by lactide and then PLA. Multiple customer interests from India and abroad have been received, with some visits already taken.
- The facility can demonstrate more than PLA: Management confirmed the facility can demonstrate multiple molecules (PHA, PHP, etc.) over time, subject to Board and Chairman approval, but said it is "too early" to answer specifically about the business model.
- Corn oil co-product strategy: A demo plant producing 4 tons per day has been commissioned at a customer site. Management declined to disclose the exact yield from a 100 KLPD corn-to-ethanol plant, citing competitive advantage. The broader co-product strategy is to extract more from existing process streams without compromising the primary output.
- SAF conversation starts in H2: Management will begin talking about Sustainable Aviation Fuel in the second half of the year, noting it has engineering and technology elements. On the U.S. ATJ pathway opportunity, 20 projects (5 crore gallons/year each) need to come up between now and 2030, each representing a $400 million potential, though with multiple dimensions around technology, EPC, risk appetite and guarantees still to resolve.
- Diesel blending tests are underway: A structured program is progressing under confidentiality clauses. For context, a 1% blending mandate would require 30-35 plants, representing ₹3,000-4,000 crores in total investment and a Praj scope of ₹1,800-2,000 crores.
Joshipura: "The idea of a co-product is that it does not compromise what's already existing, but it only allows you to extract more from the other streams that come out of the project."
CBG & 2G: Gradual Progress, One Breakthrough
- First Napier grass-exclusive CBG plant signed: This is a private sector project where the promoter has their own feedstock growing area connected to the plant, creating a closed-loop system where liquid and solid bio-fertilizers return to the same fields. It is a different client from the earlier five CBG orders.
- First international biogas order: Praj received its first international order for biogas desulfurization, from the Philippines.
- Five CBG plants progressing toward H2 invoicing: The plants from last year are advancing well, and noticeable sales and invoicing are expected in the second half of the year.
- IOCL 2G plant recommissioning on track: The cellulosic ethanol plant is progressing as per plan, with Praj working closely with the IOCL team to ramp up capacity gradually. Commissioning is expected in the second half of the year, which management calls a very important milestone for 2G ethanol.
- Cellulosic feedstock supply chain still unbuilt: Management acknowledged that the cellulosic feedstock supply chain needs to be organized by the industry and the country, but offered no timeline for when this might happen.
Joshipura: "if we can think of a plant located in the middle of a Napier grass plantation, then that is a very good one to have, because then all the nutrients that come back from the process in terms of liquid and solid bio-fertilizers can all go back to the same field, so it becomes very, very, I mean, a completely closed loop, so no water required, no, the water that comes goes back."
Margins & Below-the-Line
- Gross margin improved to 47%: The improvement came from softening raw material prices and a favorable sales mix. Management expects this range to be sustainable, with quarterly variation depending on the extent of engineering services order execution and the domestic-international mix.
- Employee costs rose on GenX and services hiring: The increase reflects resource addition at the Praj GenX subsidiary and in the services business, plus normal annual increments.
- Finance costs and depreciation rose on GenX investment: The Mangalore facility is now capitalized, so depreciation is flowing through the P&L without corresponding revenue, creating a near-term drag.
- MTM losses are non-cash and self-correcting: The mark-to-market loss on forward contracts in H1 FY25 (versus a profit in H1 FY24) is driven by adverse currency movement at the reporting date. Management emphasized these are not cash losses and get evened out over time, with no significant impact on EBITDA.
Raole: "It is mainly the mark-to-market of the forward contracts, and it is not the cash losses which we have booked."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue doubling | Management stands by the statement of doubling revenue in 3 years from today | 3 years from Q2 FY25 |
| GenX revenue ramp | Revenue from Mangalore facility to start kicking in meaningfully | Q4 FY25, definitely next year |
| Engineering order booking | Order booking to build up meaningfully from current ₹200-250 cr/quarter run-rate | H2 FY25 onwards |
| Export order inflow | Expected back to normal after large contracts missed closing in Q2 | End of nine months (Q3 FY25) |
| CBG invoicing | Noticeable sales and invoicing from five plants currently under execution | H2 FY25 |
| IOCL 2G plant commissioning | Cellulosic ethanol plant recommissioning progressing as per plan | H2 FY25 |
| Gross margin | Range expected to be more or less same as Q2's 47% | Sustainable basis |
| SAF disclosure | Company will start talking about SAF | H2 FY25 |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated income from operations | ₹816 cr, vs ₹882 cr in Q2 FY24 |
| PBT | ₹74.4 cr, vs ₹84.8 cr in Q2 FY24 |
| PAT | ₹53.8 cr, vs ₹62.3 cr in Q2 FY24 |
| H1 FY25 income from operations | ₹1,515 cr, vs ₹1,619 cr in H1 FY24 |
| H1 FY25 PBT before exceptional items | ₹153 cr, vs ₹162 cr in H1 FY24 |
| H1 FY25 PAT | ₹138 cr, vs ₹121 cr in H1 FY24 |
| Export revenue share | 27% of Q2 FY25 revenue |
| Revenue mix | 68% bioenergy, 24% engineering, 8% PHS |
| Order intake | ₹921 cr, 94% domestic; 88% bioenergy, 6% engineering, 6% PHS |
| Order backlog | ₹4,150 cr as of Sep '24, 72% domestic |
| Cash in hand | ₹751 cr as of 30th Sep '24 |
| MTM loss on forward contracts | ₹10 cr in Q2 FY25 |
| Services business order book | 40% higher in H1 FY25 than full FY24 order book for the segment |
| Domestic bioenergy order book share from starchy feedstock | 100% in Q2 FY25 |
| Gross margin | 47%, vs 50% in Q1 FY25 |